Friends in High Places
This collection features companies that strategically invest in political lobbying to influence policy and secure their competitive edge. Our analysts have carefully selected firms that leverage government relationships to create regulatory advantages and sustained profitability.
Your Basket's Financial Footprint
Concise summary and investor takeaways for the provided basket market capitalisation data.
- Large-cap dominance generally implies lower volatility, more stable returns, and closer tracking of broad market movements.
- Treat as a core holding for portfolio stability rather than a speculative, high-growth trade.
- Expect steady, long-term appreciation rather than explosive short-term gains; growth is likely moderate.
LMT: $113.27B
BA: $164.28B
XOM: $480.51B
- Other
About This Group of Stocks
Our Expert Thinking
These companies aren't just spending on lobbying—they're making strategic investments to shape regulations in their favor. By creating favorable regulatory environments and securing subsidies, these firms build powerful competitive moats that can lead to consistent long-term profitability.
What You Need to Know
This collection includes established companies in heavily regulated sectors like defense, energy, finance, and pharmaceuticals. Their significant political spending indicates a deliberate strategy of using government relationships as a business advantage, potentially offering resilience against regulatory changes.
Why These Stocks
We've identified companies that consistently rank as top spenders on lobbying and political contributions. These selections are based on public data showing both the scale and consistency of their investment in political influence, highlighting a clear strategic focus.
Why You'll Want to Watch These Stocks
Election Boost Coming
Major election cycles typically trigger increased corporate political spending as companies position themselves with potential new lawmakers. This could be a catalyst for many stocks in this collection.
Regulatory Moat Advantage
These companies aren't just playing defense against regulations—they're actively shaping the rules of their industries. This creates lasting competitive advantages that more passive competitors simply can't match.
Connected in All the Right Places
From defense contracts to energy policy and healthcare reforms, these companies have established strategic relationships with policymakers that can help them navigate changing political landscapes.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Biotech Buyout Candidates (Post-Merck Acquisition)
Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.
Cybersecurity Stocks Navigate US-China Tensions 2025
A White House memo reportedly accused Alibaba of supporting the Chinese military, intensifying the tech rivalry between the two superpowers. This escalating geopolitical tension highlights a critical need for robust cybersecurity, creating investment opportunities in companies that protect against state-level digital threats.
Berkshire AI Investment | $4.3B Alphabet Endorsement
Warren Buffett's Berkshire Hathaway has made a significant $4.3 billion investment in Alphabet, signaling a major strategic shift towards technology and AI. This move highlights the immense value in the underlying infrastructure powering the AI revolution, creating opportunities for the key suppliers of semiconductors, data centers, and networking equipment.